Bright Minds Biosciences (DRUG) Net Cash Flow Growth (3y) (2023 - 2026)

Bright Minds Biosciences (DRUG) Net Cash Flow Growth (3y) (2023 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	NCF Growth (3y) (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	89.97%
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-13.44%
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	33.37%
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Bright Minds Biosciences	16.28 Bn	16.22 Bn	-	425.29%

Download Data